Endomorphin-1 alters interleukin-8 secretion in Caco-2 cells via a receptor mediated process

Immunology Letters

Volumn 84, Issue 3, 2002, Pages 217-221

  Neudeck, Brien L ^a   Loeb, Jennifer M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Caco 2; Endomorphin 1; Interleukin 8; Opioid receptors

Indexed keywords

BETA FUNALTREXAMINE; ENDOMORPHIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; INTERLEUKIN 1; NARCOTIC ANALGESIC AGENT; OLIGOPEPTIDE;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; SECRETION;

ANALGESICS, OPIOID; CACO-2 CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-8; OLIGOPEPTIDES; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037015933     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(02)00198-0     Document Type: Article

References (21)

1. J.J Madden, R.M. Donahue, in: R.R. Watson (Ed.), Drugs of Abuse and the Immune Function, CRC Press 1990, pp. 213-228
2. Roy S., Chapin R.B., Cain K.J., Charboneau R.G., Ramakrishnan S., Barke R.A. Cell Immunol. 179:1997;1-9.
3. House R.V., Thomas P.T., Bhargava H.N. Immunol. Lett. 46:1995;117-124.
4. Sakurada S., Hayashi T., Yuhki M., Orito T., Zadina J.E., Kastin A.J., Fujimura T., Murayama K., Sakurada C., Sakurada T., Narita M., Suzuki T., Tan-no K., Tseng L.F. Eur. J. Pharmacol. 427:2001;203-210.
5. Xie G.X., Meuser T., Pietruck C., Sharma M., Palmer P.P. Life Sci. 64:1999;2029-2037.
6. Grimm M.C., Ben-Baruch A., Taub D.D., Howard O.M., Resau J.H., Wang J.M., Ali H., Richardson R., Snyderman R., Oppenheim J.J. J. Exp. Med. 188:1998;317-325.
7. Choi Y., Chuang L.F., Lam K.M., Kung H.F., Wang J.M., Osburn B.I., Chuang R.Y. In Vivo. 13:1999;389-396.
8. Wetzel M.A., Steele A.D., Eisenstein T.K., Adler M.W., Henderson E.E., Rogers T.J. J. Immunol. 165:2000;6519-6524.
9. Milovic V., Bauske R., Turchanowa L., Stein J. Ann. New York Acad. Sci. 915:2000;279-281.
10. Artursson P., Palm K., Luthman K. Adv. Drug Deliv. Rev. 46:2001;27-43.
11. Chowers Y., Cahalon L., Lahav M., Schor H., Tal R., Bar-Meir S., Levite M. J. Immunol. 165:2000;2955-2961.
12. Steiner T.S., Nataro J.P., Poteet-Smith C.E., Smith J.A., Guerrant R.L. J. Clin. Invest. 105:2000;1769-1777.
13. Casola A., Estes M.K., Crawford S.E., Ogra P.L., Ernst P.B., Garofalo R.P., Crowe S.E. Gastroenterology. 114:1998;947-955.
14. Yang S.K., Eckmann L., Panja A., Kagnoff M.F. Gastroenterology. 113:1997;1214-1223.
15. Roy S., Wang J.H., Balasubramanian S., Sumandeep, Charboneau R., Barke R., Loh H.H. J. Neuroimmunol. 116:2001;147-155.
16. Roy S., Loh H.H., Barke R.A. Adv. Exp. Med. Biol. 373:1995;41-48.
17. Peterson P.K., Sharp B., Gekker G., Brummitt C., Keane W.F. J. Clin. Invest. 80:1987;824-831.
18. Carr D.J., Radulescu R.T., deCosta B.R., Rice K.C., Blalock J.E. Life Sci. 47:1990;1059-1069.
19. Kowalski J. Neuropeptides. 32:1998;301-306.
20. Chao C.C., Hu S., Shark K.B., Sheng W.S., Gekker G., Peterson P.K. J. Pharmacol. Exp. Ther. 281:1997;998-1004.
21. Daig R., Andus T., Aschenbrenner E., Falk W., Scholmerich J., Gross V. Gut. 38:1996;216-222.